Chad A. Landmon spoke at the CBI's 4th Annual Bio/Pharmaceutical Drug Safety Forum, which was held on March 12 and 13, 2012 in Philadelphia, PA.  Chad discussed product liability failure to warn cases and the impact of different legal standards for labeling of branded and generic products.